Head and neck cancer PDXs can be generated for a wide range of tumor characteristics. A 24-h delay post surgical resection does not impact engraftment rate. Protein expression biomarkers are stable across PDX passages. Mutational profile of PDXs are stable from patient tumor to multiple PDX generations.